New disease model to facilitate development of ALS and MS therapies
Researchers at Karolinska Institutet in Sweden have developed a new disease model for neurodegenerative diseases such as ALS and MS that can be used to develop new immunotherapies. The model is described in a publication ...
Apr 17, 2018
0
107